Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems

Process Analytical Technology For Upstream Bioprocessing

Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER

Volume Reduction and Process Optimization with Cadence Inline Concentrator

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

View All Featured Articles

Headline News

Lilly unveils Change the Course Commitment aimed at closing diabetes and obesity treatment gaps in lower-income countries

Lilly’s Foundayo at 17.2 mg outperforms 25 mg oral semaglutide on weight loss and A1C reduction, new indirect treatment comparison finds

Pfizer to showcase new cancer research spanning current standards of care and emerging pipeline breakthroughs at ESMO 2026

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

New Technologies for Improving and Controlling Product Quality, Expression, Timelines and Yield in Upstream Process Development

Presented by Niki Wong, Principal Research Scientist at AbbVie Operations Singapore Pte Ltd
07th April 2020

Implementation Strategies and Challenges for Single-Use Technologies at Commercial Scale

Presented by Adam Goldstein, Roche/Genentech and Jacob McNeil, Thermo Fisher Scientific
17th May 2018

Viral Safety by Design for Cell and Gene Therapy Products

Presented by Mark Plavsic, Chief Technology Officer at Lysogene and Dr. Magali Roche, Sales Manager, PathoQuest, Biologics Genomic Service
16th October 2020

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos